Tri Locum Partners LP Novavax Inc Transaction History
Tri Locum Partners LP
- $374 Million
- Q3 2024
A detailed history of Tri Locum Partners LP transactions in Novavax Inc stock. As of the latest transaction made, Tri Locum Partners LP holds 10,600 shares of NVAX stock, worth $91,160. This represents 0.6% of its overall portfolio holdings.
Number of Shares
10,600Holding current value
$91,160% of portfolio
0.6%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding NVAX
# of Institutions
286Shares Held
94.8MCall Options Held
6.95MPut Options Held
9.4M-
Vanguard Group Inc Valley Forge, PA15.4MShares$133 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$102 Million0.0% of portfolio
-
Shah Capital Management11.1MShares$95.9 Million35.54% of portfolio
-
State Street Corp Boston, MA7.69MShares$66.1 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY5.94MShares$51.1 Million0.07% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $673M
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...